ArticleMDM policy & practice
Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?
Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?Applied health economics and health policy · 2023Pooled it
- Using FIT Thresholds for Priority Triage and Risk Stratification in Resource-Constrained Systems.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Variation in diagnostic performance of fecal immunochemical test (FIT) by cutoffs used in screening programs globally.EClinicalMedicine · 2026Article
- Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer Outcomes.Gastro hep advances · 2026Article
- Adherence to Multitarget Stool DNA Testing in Individuals Aged 45-49 Years With Average Risk for Colorectal Cancer.Clinical and translational gastroenterology · 2025Article
- Levelling up as a fair solution in AI enabled cancer screening.Frontiers in digital health · 2025Article
- Cost consequences of unscheduled emergency admissions in cancer patients in the last year of life.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review protocol.Systematic reviews · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.